                            NIH Public Access
                            Author Manuscript
                            J Biol Chem. Author manuscript; available PMC 2013 October 07.
                           Published final edited form 
NIH-PA Author Manuscript




                            J Biol Chem. 1999 December 31; 274(53): 37781â€“37786.



                           Essential Protein-Protein Interactions Plasmodium
                           falciparum Thymidylate Synthase Dihydrofolate Reductase
                           Domains*
                           Shamira Shallom, Kai Zhang, Lei Jiang, Pradipsinh K. Rathodâ€¡
                           Department Biology, Catholic University America, Washington, D. C. 20064

                           Abstract
                                Plasmodium falciparum, dihydrofolate reductase thymidylate synthase activities                                 conferred single 70-kDa bifunctional polypeptide (DHFR-TS, dihydrofolate reductase-
                                thymidylate synthase) assembles functional 140-kDa homodimer. mammals,                                 enzymes smaller distinct molecules encoded different genes. 27-kDa amino domain
NIH-PA Author Manuscript




                                malarial DHFR-TS sufficient provide DHFR activity, structural requirements                                 TS function established. 3â€²-end DHFR-TS high homology                                 TS sequences species, expression protein fragment failed yield active TS
                                enzyme, failed complement TSâˆ’ Escherichia coli. Unexpectedly, partial 5â€²-deletion
                                length DHFR-TS gene abolished TS function 3â€²-end.  hypothesized                                 amino end bifunctional parasite protein plays important role TS function.                                 27-kDa amino domain (DHFR) provided trans, previously inactive 40-kDa carboxyl-
                                domain malarial DHFR-TS regained TS function. Physical characterization â€œsplit
                                enzymesâ€? revealed 27- 40-kDa fragments DHFR-TS reassembled                                 140-kDa hybrid complex.  malarial DHFR-TS, physical interactions                                 DHFR domain TS domain, interactions necessary obtain catalytically
                                active TS. Interference essential protein-protein interactions lead new selective
                                strategies treat malaria resistant traditional DHFR-TS inhibitors.

                                             Malaria, caused protozoan parasite Plasmodium falciparum, affects 300 million
                                             individuals causes 2 million death year (1). Traditional antimalarial agents
                                             chloroquine ineffective regions world drug resistance (2,
                                             3). addition, mounting evidence highly drug-resistant parasite clones acquire
NIH-PA Author Manuscript




                                             resistance new antimalarial agents enhanced rate (4, 5). Identification host-
                                             parasite biochemical differences lead selective chemotherapy important
                                             

                                             malaria cell types, chemotherapy targeted dihydrofolate
                                             reductase (DHFR)1 thymidylate synthase (TS) proven highly effective (6, 7).
                                             partial inhibition DHFR TS lead DNA strand fragmentation cell death
                                             (8 â€“10). malaria pharmacology, enzymes particular 

                            work supported United States Public Health Service Grants AI26912 AI40956 National Institutes                            Health.
                           Â© 1999 American Society Biochemistry Molecular Biology, 
                           correspondence addressed: Dept. Biology, Catholic University America, 620 Michigan Ave., N.E.,
                           Washington D. C. 20064. Tel.: 202-319-5278; Fax: 202-319-5721; rathod@cua.edu.
                           â€¡Recipient Burroughs Wellcome Fund New Initiatives Malaria Research award.
                           1The abbreviations used  DHFR, dihydrofolate reductase; TS, thymidylate synthase.
                            Shallom et al.                                                                                            Page 2


                                            traditional drugs pyrimethamine cycloguanil known inhibit parasite
                                            DHFR-TS (11â€“13). recent years,  effectiveness inhibitors                                             compromised malarial parasite strains expressing mutant forms DHFR-TS (14 â€“16).
NIH-PA Author Manuscript




                                            obvious way continue selective killing malarial parasites identify new folate
                                            analogs directed DHFR- TS-active sites effective drug-resistant
                                            parasites (17â€“20).

                                            active site-directed strategies, non-traditional opportunities inhibit
                                            malarial DHFR-TS selectivity. protozoan parasites, including Plasmodia,                                             single bifunctional protein codes DHFR TS activity (21â€“24). sharp
                                            contrast, mammalian cells  bacteriophage, bacteria, yeast) separate
                                            genes code small monofunctional DHFR TS proteins (25, 26). difference                                             organization established drug targets represents dramatic difference host-
                                            parasite biochemistry.  clear bifunctional status DHFR-TS
                                            play role selective chemotherapy.  indications active sites                                             DHFR TS bifunctional proteins operate independently  Inhibition
                                            DHFR methotrexate does influence TS activity, inhibition TS function
                                            5-fluoro-2â€²-deoxyuridylate does effect DHFR activity (27). structure                                             Leishmania DHFR-TS suggests active sites DHFR-TS 40 Ã… apart (28).
                                            Designing â€œdouble-barrel,â€? parasite-specific bifunctional DHFR-TS inhibitor                                             practical goal present. Second, kinetic measurements suggest Leishmania NIH-PA Author Manuscript




                                            Toxoplasma TS channel 8 10 dihydrofolate (DHF) molecules directly
                                            TS site DHFR site (27, 29, 30).  Leishmania DHFR-TS structure
                                            indicates direct channeling attributed electropotential gradient                                             bifunctional protein leads TS folate-binding site DHFR folate-binding
                                            site (28, 29).  highly unlikely blocking channeling lead                                             selective antimalarial chemotherapy malarial DHFR-TS active sites                                             trouble delivering accepting substrates bulk solvent vitro (31, 32) vivo
                                            (33).

                                            study, demonstrate species-specific interactions malarial DHFR
                                            domain TS domain essential functioning enzymes. Inhibition                                             protein-protein interactions offer powerful new strategy selective chemotherapy
                                            malaria possibly protozoan parasites.

                              EXPERIMENTAL PROCEDURES
                              Materials
                                            Trimethoprim, ampicillin, tetracycline, leucine, proline, thymidine, 2â€²-deoxyuridylate, 5-
NIH-PA Author Manuscript




                                            fluoro-2â€²-deoxyuridylate, dihydrofolate, methotrexate-agarose Sigma.
                                            Oligonucleotides synthesized Operon (Alameda, CA). Escherichia coli strains
                                            BL21, BL21(DE3), DE3 lysogenization kit Novagen (Madison, WI). E.
                                            coli strain Rue10 (thyAâˆ’) Chen-Chen Kan (Agouron Pharmaceuticals).

                              Plasmids
                                            Plasmid pKK233.2 P. falciparum DHFR-TS coding sequence clone K1                                             obtained John Hyde (University Manchester) maintained described
                                            previously (34). Plasmids pET23d(+) Novagen (Madison, WI). plasmid
                                            cut NcoI HindIII modified express different domains P. falciparum
                                            DHFR-TS (Fig. 1). pET-DHFR designed express amino acids 1â€“230 P.
                                            falciparum DHFR-TS coding region (32, 34); pET-TS31 expressed amino acids 325â€“ 607                                             P. falciparum DHFR-TS coding region; pET-TS40 coded amino acids 249 â€“ 607


                                                J Biol Chem. Author manuscript; available PMC 2013 October 07.
                            Shallom et al.                                                                                           Page 3


                                            P. falciparum DHFR-TS coding region, pET-DHFR-TS contained length
                                            coding region (Fig. 1).
NIH-PA Author Manuscript




                              Antibody P. falciparum DHFR Domain
                                            antigen, malarial DHFR domain, expressed purified methotrexate-affinity
                                            column described previously (32). Rabbit polyclonal antibodies pure protein                                             raised Josman Laboratories (Napa, CA). P. falciparum DHFR-specific antibody                                             purified affinity chromatography using P. falciparum DHFR domain attached                                             Aminolink Plus Pierce.

                              Genetic Complementation Assay TS Function
                                            thymidylate synthase-deficient E. coli strain Rue10 lysogenized Î»DE3                                             provide T7 RNA polymerase function host (36). host cells maintained                                             LB medium presence leucine (40 Î¼g/ml), proline (200 Î¼g/ml), thymidine (100
                                            Î¼g/ml). testing TS function pET plasmids bearing malarial DHFR-TS gene,                                             portions gene, 50 ng plasmid electroporated 4 Ã— 107
                                            electrocompetent Rue10(DE3) cells. cells spread sets ampicillin agar
                                            plates, thymidine lacking thymidine.

                              Genetic Complementation Assay Malarial DHFR Function
NIH-PA Author Manuscript




                                            Appropriate pET plasmids electroporated BL21(DE3) cells  cells
                                            spread sets ampicillin agar plates, trimethoprim (50 Î¼g/ml)                                              Bacterial DHFR sensitive trimethoprim malarial DHFR (34).

                              Exonuclease Treatment DNA Fragment Coding Malarial DHFR-TS
                                            5â€²-deletion experiment involved following steps prior testing TS
                                            function:   generation DNA strand malarial DHFR-TS sequence                                             susceptible exonuclease 5â€²-end 3â€²-end; (ii) digestion long
                                            fragment exonuclease varying amounts time generate series short DNA
                                            fragments varying length; (iii) preparation recipient vector AUG start codon;
                                            (iv) ligation short partially digested fragments recipient vector.

                                            Initially, 12 Î¼g pET23d(+) plasmid length malarial DHFR-TS insert                                             digested 24 units PvuII 24 units PstI total volume 40 Î¼l 6 h.                                             purified 3900-base pair fragment containing DHFR-TS sequence susceptible                                             exonuclease III PvuII end PstI end. initiate digestion 5â€²-end, 6
                                            Î¼g DNA placed 60 Î¼l ExoIII buffer (Erase-abase kit, Promega, Madison, WI).
                                            2.5-Î¼l aliquot removed time 0. Digestion started 400 units exonuclease
NIH-PA Author Manuscript




                                            III delivered 2.3-Î¼l volume. conditions, digestion occurred rate 80 â€“90
                                            base pairs min 22â€“25 Â°C. Aliquotes 2.5 Î¼l removed 2.5 min 60 min.
                                            treated S1 nuclease blunt-ended Klenow described (Erase 
                                            base kit, Promega, Madison, WI). cohesive end 3â€²-end DHFR-TS coding
                                            region generated treating 2.5-min samples HindIII.

                                            recipient plasmid expressing exonuclease-treated DNA generated                                             cutting 5 Î¼g pET23d(+) 6 units NcoI. NcoI-digested plasmid blunt-ended
                                            Klenow (10 units, room temperature, 14 min) digested HindIII (24 units,
                                            37 Â°C, 4 h) generate cohesive site end vector. Approximately 760 ng
                                            exonuclease-digested DNA (5 Î¼l) ligated 312 ng recipient vector. ligation
                                            products 2.5-min time point transformed electrocompetent
                                            Rue10(DE3) cells plated thymidine measure TS function, ligated DNA


                                                J Biol Chem. Author manuscript; available PMC 2013 October 07.
                            Shallom et al.                                                                                          Page 4


                                            transformed electrocompetent BL21(DE3) cells plated trimethoprim plates
                                            measure DHFR function  .
NIH-PA Author Manuscript




                              transformation E. coli Rue10(DE3) Plasmids Coding DHFR Fragment
                              TS Fragment
                                            step, pET-DHFR transformed Rue10(DE3) selected ampicillin
                                            resistance. Rue10(DE3)pET-DHFR electrocompetent, transformed                                             pET-TS40, selected growth medium lacking thymidine. Subsequently,                                             double transformants obtained transforming cells pET-
                                            TS40 (selection ampicillin plates) transforming pET-DHFR
                                            (selection medium thymidine).

                              Physical Characterization P. falciparum TS40 + DHFR Split Protein
                                            E. coli Rue10(DE3), transformed pET-DHFR pET-TS40, freshly grown                                             absorbance 1.0 600 nm. cells collected centrifugation resuspended
                                            50 mM Tris-HCl, pH 8, 2 mM EDTA, 0.1  Triton X-100, 0.1 mg/ml lysozyme (final
                                            lysis volume 1/10 original culture volume). cells incubated 30 Â°C                                             15 min, sonicated, stored 1-ml aliquots âˆ’20 Â°C.

                                            estimate native size DHFR TS activities gel filtration chromatography,
                                            200 Î¼l cell lysate applied 1 Ã— 50 cm Superdex 200 column
NIH-PA Author Manuscript




                                            (Amersham Pharmacia Biotech). buffer gel filtration 50 mM Tris-HCl, pH 8, 2
                                            mM EDTA, 10  glycerol, 0.1 M NaCl, 2 mM dithiothreitol. flow rate 0.25 ml/min,
                                            0.5-ml fractions collected.

                                            split protein purified homogeneity using methotrexate affinity chromatography.
                                            total 10 ml cell lysate double-transformed E. coli Rue10(DE3) applied
                                            2-ml methotrexate-agarose column pre-equilibrated 50 mM Tris-HCl, pH 8, 2 mM
                                            EDTA, 10  glycerol, 0.5 M NaCl, 2 mM dithiothreitol. column washed                                             20 ml equilibration buffer active fractions eluted buffer
                                            plus 4 mM dihydrofolate. ml fractions collected.

                              Assay TS Activity Malarial DHFR Protein
                                            chromatography step, malarial TS activity monitored assaying 10 Î¼l                                             fraction using 5-[3H]-2â€²deoxyuridylate tritium release assay (34). Malarial DHFR
                                            activity monitored Western blotting fraction. 10-Î¼l sample tube
                                            applied 10  SDS-polyacrylamide gel electrophoresis                                              separation, protein transferred polyvinylidene difluoride membrane. Malarial
NIH-PA Author Manuscript




                                            DHFR detected using affinity purified polyclonal antibodies malarial DHFR domain
                                             , goat anti-rabbit secondary antibodies, Western-Star chemiluminescent
                                            detection (Tropix, , Bedford, MA). assay easily detected 1 ng malarial
                                            DHFR.

                              RESULTS DISCUSSION
                              Carboxyl End Malarial DHFR-TS Insufficient TS Function
                                            amino-terminal DHFR domain malarial DHFR-TS expressed functional
                                            form (32, 34, 37, 38), attempts express carboxyl end TS domain                                             catalytically active form unsuccessful. genetic used assay TS
                                            function malarial DHFR-TS gene. E. coli cells lacking TS function (strain Rue10)
                                            normally proliferate presence thymidine absence thymidine (39).
                                            Lysates prepared Rue10 cells DHFR enzyme activity TS activity (data 

                                                J Biol Chem. Author manuscript; available PMC 2013 October 07.
                            Shallom et al.                                                                                            Page 5


                                            shown). Rue10 cells transformed expression plasmid coding 
                                            length malarial DHFR-TS gene (Fig. 1A), E. coli Rue10 proliferate absence                                             thymidine (Fig. 1B). Transformation plasmids coding minimal 30-kDa â€œTS
NIH-PA Author Manuscript




                                            domainâ€? (Fig. 1A) 40-kDa protein coding joining region                                             TS domain (Fig. 1A) failed rescue Rue10 thymidine dependence (Fig. 1B).                                             experiments suggested carboxyl end TS domain, defined sequence homology                                             monofunctional TS proteins, sufficient express functional TS protein.

                              Partial 5â€²-Deletion Malarial DHFR-TS Abolishes TS Function
                                            order define minimum 5â€²-end functional TS domain, length malarial
                                            DHFR-TS gene subjected unidirectional exonuclease III treatment varying
                                            durations (Fig. 2A). resulting fragments blunt-ended cloned recipient
                                            expression vector equipped blunt-ended AUG start codon. ligation mixes
                                            time point transformed E. coli Rue10(DE3) scored TS function
                                            (colonies growing thymidine) malarial DHFR function (colonies growing                                             presence trimethoprim). results showed following:   DHFR TS function
                                            lost simultaneously (Fig. 2B); (ii) colony survived plates                                             thymidine, replica plated, malarial DHFR function TS function (data                                             shown); (iii) DNA sequencing inserts TS+ E. coli showed intact
                                            malarial DHFR-TS gene (data shown). Control experiments confirmed repeated
                                            recovery just length DHFR-TS inability digest gene high
NIH-PA Author Manuscript




                                            processivity exonuclease. early 5â€²-digestion experiment, degradation
                                            malarial DHFR-TS gene visualized directly agarose gel (data shown).
                                            Intermediate sized fragments appropriate length observed DHFR-TS                                             treated exonuclease 5â€“20 min  schematic Fig. 2A). Additionally, selection
                                            transformants presence thymidine allowed recovery inserts incomplete
                                            DHFR-TS fragments (data shown). experiments consistent                                             hypothesis â€œcarboxyl end TS domainâ€? malarial parasites adequate                                             obtain functional TS enzyme. Furthermore, exonuclease experiment suggested                                             amino end malarial DHFR-TS necessary TS function.

                              DHFR Domain Activate TS Domain Trans
                                            test directly contributions malarial DHFR domain TS function, E. coli
                                            Rue10 transformed 40-kDa carboxyl TS domain supplemented 27-
                                            kDa DHFR domain trans selected medium lacking thymidine. results showed
                                            simultaneous transformation ThyAâˆ’ E. coli expression vector coding
                                            40-kDa TS domain expression vector coding amino end DHFR fully
                                            rescued TS defect (Fig. 3). plasmids introduced order (data
NIH-PA Author Manuscript




                                            shown). Polymerase chain reaction analysis demonstrated TS function truly
                                            restored genes acting trans. distinct plasmids rescued E. coli,
                                            evidence new bifunctional gene created recombination
                                            plasmids (data shown). Direct biochemical TS assay cell lysates showed
                                             expected, double transformed E. coli proliferated thymidine
                                            expressed active TS enzyme (data shown). experiments demonstrated
                                            unambiguously amino-terminal DHFR domain malarial DHFR-TS necessary
                                            carboxyl-terminal TS sequence gain TS function. TS31 domain                                             rescued DHFR domain (data shown), â€œjoining regionâ€? make
                                            significant contacts malarial DHFR domain. requirement DHFR domain
                                            species-specific endogenous E. coli DHFR activate malarial TS
                                            sequence expressed bacterial host.




                                                J Biol Chem. Author manuscript; available PMC 2013 October 07.
                            Shallom et al.                                                                                              Page 6


                              Physical Associations Split Protein
                                            general ways malarial DHFR domain activating TS
                                            function TS domain:   DHFR domain acted transient chaperon
NIH-PA Author Manuscript




                                            folding TS sequence, (ii) DHFR domain formed stable
                                            association carboxyl-terminal TS. determine stable association
                                            DHFR TS domains split protein, physical characteristics                                             active proteins double transformed E. coli studied.  cell lysate E.
                                            coli Rue10(DE3) pET-DHFR, pET-TS40, subjected gel filtration chromatography.
                                            TS activity malarial DHFR emerged single superimposing peak (Fig. 4A). size
                                            TS + DHFR complex 140,000 daltons. consistent hypothesis
                                            DHFR TS fragments assembled tetramer 40-kDa TS
                                            units 27-kDa DHFR units, reestablishing natural relationship                                             domains. reasonable alternative structures inconsistent gel filtration data.
                                            free DHFR domain mass 27 kDa seen gel filtration column.                                             did DHFR-free obligate TS dimer mass 80 kDa.

                                            TS + DHFR split protein formed complex stable survive gel filtration
                                            chromatography, chose purify complex homogeneity study physical
                                            characteristics. Cell lysates double-transformed E. coli Rue10(DE3) passed
                                            methotrexate affinity column, known bind malarial DHFR domain
                                            (32). unbound protein eluted 500 mM salt, specifically bound protein NIH-PA Author Manuscript




                                            eluted 4 mM dihydrofolate (Fig. 4B). TS activity malarial DHFR
                                            activities eluted simultaneously 4 mM dihydrofolate fractions. active fractions
                                            concentrated subjected SDS-polyacrylamide gel electrophoresis (Fig. 4C).
                                            Coomassie Blue staining revealed bands, mass 40 kDa                                             mass 27 kDa. Careful densitometry revealed 27- 40-kDa bands                                             present stoichiometric ratio 1 0.97, compensating size differences.                                             larger 40-kDa band labeling radioactive 5-fluoro-2â€²-deoxyuridylate                                             predict catalytically active TS domain (Fig. 4C). smaller band, 27-kDa,
                                            shown malarial DHFR domain Western blotting (Fig. 4C). final purified
                                            material DHFR-specific activity 39.2 Î¼mol/min/mg total protein. Assuming                                             kcat 1800/min DHFR, consistent protein having 27-kDa
                                            DHFR subunits attached 40-kDa TS subunits. sum, physical characteristics                                             purified split protein support gel filtration studies consistent model
                                            DHFR TS domains assemble form 140-kDa tetramer.                                             experiments interactions DHFR domain TS domain                                             lead activation TS function transient; split malarial DHFR domain                                             40-kDa domain reassemble form stable complex reflects natural state                                             bifunctional protein (Fig. 5).
NIH-PA Author Manuscript




                                            present study uses combination genetic biochemical approaches demonstrate
                                            species-specific interactions malarial DHFR domain TS domain                                             essential TS function.

                                            malarial DHFR-TS structure available, crystal structure Leishmania
                                            major DHFR-TS bifunctional protein offers obvious clue amino end                                             DHFR domain act determinant TS function. Leishmania enzyme 22-
                                            amino acid extension amino terminus DHFR domain encircles                                             attached TS domain (28).  polypeptide extension amino end                                             DHFR domain appears necessary stabilize tertiary structure TS domain,                                             conceivable residues extended polypeptide contribute directly
                                            formation TS-active site. malarial DHFR shorter extension
                                            amino end (21), conceivable directly interacts residues TS

                                                J Biol Chem. Author manuscript; available PMC 2013 October 07.
                            Shallom et al.                                                                                                             Page 7


                                            domain necessary form catalytically active TS enzyme. course,                                             possible  unlike Leishmania bifunctional protein, amino end malarial
                                            DHFR domain necessary primarily stabilize DHFR tertiary structure 
NIH-PA Author Manuscript




                                            indirectly, influences correct folding activity malarial TS domain.

                                            Regardless mechanistic details underlying activation TS domain amino
                                            end DHFR domain, inhibition species-specific protein-protein interactions
                                            offer powerful new strategy selective chemotherapy malaria possibly
                                            protozoan parasites. Small molecular weight peptidomimetics disrupt                                             interactions domains fail activate TS expected inhibit malarial TS
                                            selectivity human TS does require â€œactivationâ€? accessory protein.
                                            precedence drug development inspired species-specific protein-protein
                                            interactions. instance, virus-specific interactions subunits                                             ribonucleotide reductase herpes simplex virus led selective peptidomimetic
                                            inhibitors effective nanomolar concentrations (40). addition, inhibition                                             protein-protein interactions considered systems including dimerization                                             HIV proteases, assembly herpes simplex virus DNA polymerase subunits, interactions
                                            involving G-proteins signal transduction machinery, binding adhesion molecules
                                            surface proteins platelets (41).

                                            present E. coli genetic assay malarial TS function expected play powerful role
NIH-PA Author Manuscript




                                            future mutagenesis experiments help establish contact sites                                             malarial protein domains. addition, present genetic serve high
                                            throughput screens identify selective inhibitors malarial TS function. Finally,                                             present  hybridâ€? genetic provides novel means maintaining plasmids
                                            indefinitely selectable drug marker.

                              Acknowledgments
                                            P. K. R. grateful Chen-Chen Kan (Agouron Pharmaceuticals) E. coli Rue10 cells, John Hyde
                                            (University Manchester) length DHFR-TS gene, Dan Herschlag, (Stanford University)                                             valuble discussions.


                              References
                                            1. Oaks, SC., Jr; Mitchell, VS.; Pearson, GW.; Pearson, CCJ., editors. Malaria. National Academy
                                               Press; Washington, D. C: 1991.
                                            2. White NJ. J Antimicrob Chemother. 1992; 30:571â€“585. [PubMed: 1493976]
                                            3. Su XZ, Kirkman LA, Fujioka H, Wellems TA. Cell. 1997; 91:593â€“603. [PubMed: 9393853]
                                            4. Rathod PK, McErlean T, Lee PC. Proc Natl Acad Sci U S  1997; 94:9389â€“9393. [PubMed:
NIH-PA Author Manuscript




                                               9256492]
                                            5. White NJ, Olliaro PL. Parasitol Today. 1996; 12:399â€“401. [PubMed: 15275291]
                                            6. Hillcoat BL, Blakely RL. J Biol Chem. 1966; 241:2995â€“3001. [PubMed: 4957970]
                                            7. Hitchings GH. Clin Pharmacol Ther. 1960; 1:570â€“589.
                                            8. Houghton PJ, Germain GS, Hazelton BJ, Pennington JW, Houghton JA. Proc Natl Acad Sci U S 
                                               1989; 86:1377â€“1381. [PubMed: 2537495]
                                            9. Ingraham HA, Dickey L, Goulian M. Biochemistry. 1986; 25:3225â€“3230. [PubMed: 3524674]
                                            10. Yoshioka  Tanaka S, Hiraoka O, Koyama Y, Hirota Y, Ayusawa D, Seno T, Garrett C, Wataya
                                                 Y. J Biol Chem. 1987; 262:8235â€“8241. [PubMed: 2954951]
                                            11. Hitchings GH. Clin Pharmacol Ther. 1960; 1:570â€“589.
                                            12. Russel PB, Hitchings GH. J Chem Soc. 1951; 73:3763â€“3770.
                                            13. Spinks  Tottey MM. Ann Trop Med. 1945; 39:220â€“224.




                                                 J Biol Chem. Author manuscript; available PMC 2013 October 07.
                            Shallom et al.                                                                                             Page 8


                                            14. Foote SJ, Galatis D, Cowman AF. Proc Natl Acad Sci U S  1990; 87:3014â€“3017. [PubMed:
                                                2183221]
                                            15. Peterson DS, Milhous WK, Wellems TE. Proc Natl Acad Sci U S  1990; 87:3018â€“3022.
NIH-PA Author Manuscript




                                                [PubMed: 2183222]
                                            16. Nzila-Mounda  Mberu EK, Sibley CH, Plowe CV, Winstanley PA, Watkins WM. Antimicrob
                                                Agents Chemother. 1998; 42:164â€“169. [PubMed: 9449279]
                                            17. Canfield CJ, Milhous WK, Ager AL, Rossan RN, Sweeney TR, Lewis NJ, Jacobus DP. J Trop
                                                Med Hyg. 1993; 49:121â€“126. [PubMed: 8352384]
                                            18. Winstanley PA, Mberu EK, Szwandt  Breckenridge  Watkins WM. Antimicrob Agents
                                                Chemother. 1995; 39:948â€“952. [PubMed: 7786001]
                                            19. Hekmat-Nejad M, Rathod PK. Exp Parasitol. 1997; 87:222â€“228. [PubMed: 9371087]
                                            20. Rathod PK, Reshmi S. Antimicrob Agents Chemother. 1994; 38:476â€“480. [PubMed: 8203840]
                                            21. Bzik DJ, Li W, Horii T, Insulburg J. Proc Natl Acad Sci U S  1987; 84:8360â€“8364. [PubMed:
                                                2825189]
                                            22. Beverley SM, Ellenberg TE, Cordingley JS. Proc Natl Acad Sci U S  1986; 83:2584â€“2588.
                                                [PubMed: 3458220]
                                            23. Chen G, Zolg JW. Mol Pharmacol. 1987; 32:723â€“730. [PubMed: 3320742]
                                            24. Garrett CE, Coderre JA, Meek TD, Garvey EP, Claman D, Beverly SM, Santi DV. Mol Biochem
                                                Parasitol. 1984; 11:257â€“265. [PubMed: 6749182]
                                            25. Huennekans FM. Protein Sci. 1996; 5:1201â€“1208. [PubMed: 8762155]
                                            26. Carreras CW, Santi DV. Annu Rev Biochem. 1995; 64:721â€“762. [PubMed: 7574499]
NIH-PA Author Manuscript




                                            27. Meek TD, Garvey EP, Santi DV. Biochemistry. 1985; 24:678â€“686. [PubMed: 3922404]
                                            28. Knighton RR, Kan CC, Howland E, Janson CA, Hostomska  Welsh KM, Mathews DA. Nat
                                                Struct Biol. 1994; 1:186â€“194. [PubMed: 7656037]
                                            29. Elcock AH, Potter MJ, Matthews DA, Knighton DR, McCammon JA. J Mol Biol. 1996; 262:370â€“
                                                374. [PubMed: 8845002]
                                            30. Trujillo M, Donald RG, Roos DS, Greene PJ, Santi DV. Biochemistry. 1996; 35:6366â€“6374.
                                                [PubMed: 8639582]
                                            31. Hekmat-Nejad M, Rathod PK. Antimicrob Agents Chemother. 1996; 40:1628â€“1632. [PubMed:
                                                8807052]
                                            32. Hekmat-Nejad M, Lee P, Rathod PK. Exp Parasito